Biotech
Major bio firm Alteogen seeks KOSPI listing
An Ruwaito ta hanyar AI Hoton da AI ya samar
Alteogen, the top market cap company on South Korea's secondary KOSDAQ market, has decided to move to the main KOSPI bourse to secure stable funding and enhance its corporate value. Shareholders approved the proposal on Monday, with the firm aiming for a listing next year.
A San Francisco startup has begun testing a brain implant in humans that aims to detect and one day treat cancer. Three people have received the device so far.
An Ruwaito ta hanyar AI
Nuvation Bio Inc. conducted its first quarter 2026 earnings call on May 4, 2026. The company reviewed financial results for the period ending March 31, 2026, and provided a business update. Executives including CEO David Hung participated in the discussion.
This week saw U.S.-based startups raise significant venture capital, led by $500 million rounds for cryptocurrency firm Ripple and AI parking platform Metropolis. The funding spanned sectors including biotech, cybersecurity, and neurotech. The total for the top 10 rounds exceeded $2 billion, highlighting continued investor interest in innovative technologies.
An Ruwaito ta hanyar AI
Scientists have created a new therapy combining LED technology and nanomaterials to eliminate cancer cells through localized heat, avoiding damage to healthy tissue. This approach aims to provide a safer alternative to traditional chemotherapy and radiotherapy.
Bangkok announced it will host the We Are The World Biotech – AI Innovative & Integrated East-West Medicine Global Summit in November 2025. The event focuses on integrating biotech, AI, and traditional medicine. This nonprofit initiative promotes global health collaboration.
An Ruwaito ta hanyar AI
Biotech company Summit announced promising results from its lung cancer drug in recent trials. The drug demonstrated potential efficacy in treating advanced cases, marking a step forward in oncology treatments. Further studies are planned to confirm these findings.
Isomorphic Labs’ AI-designed drugs advance to human trials
April 06, 2026 23:47Chinese regulator discourages red-chip structures in sensitive industries
March 17, 2026 16:03US reshoring casts shadow over China’s contract drug makers, analyst says
January 29, 2026 20:23Chinese startup Gestala develops noninvasive brain-computer interface
January 10, 2026 00:46Jennifer Doudna cofounds startup for tailored gene-editing treatments
October 27, 2025 03:28Beyond Meat investor eyes ETHZilla after stock rally
September 15, 2025 00:14Stem Cell EVs Aid Tissue Repair
September 15, 2025 00:14Vaccine Therapy Progress for Brain Tumors
September 15, 2025 00:14Cellular Treatment Outperforms Chemo in Cancer Models
September 11, 2025 00:22Summit's Lung Cancer Drug Progress